2,652 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Acquired by CenterStar Asset Management LLC

CenterStar Asset Management LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,652 shares of the financial services provider’s stock, valued at approximately $386,000.

Other hedge funds have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC acquired a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $27,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $31,000. Pacifica Partners Inc. lifted its position in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 130 shares during the period. Mather Group LLC. acquired a new position in shares of iShares Biotechnology ETF in the 1st quarter worth approximately $57,000. Finally, Chris Bulman Inc acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $64,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.7 %

Shares of NASDAQ IBB traded up $2.44 during midday trading on Friday, reaching $145.59. The stock had a trading volume of 2,178,921 shares, compared to its average volume of 1,483,730. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The company’s 50 day moving average price is $145.12 and its 200 day moving average price is $139.36.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.